Read More Pharma Industry News Boehringer Ingelheim’s SENVELGO gets EU marketing authorization for feline diabetes treatment The European Commission has granted marketing authorization to Boehringer Ingelheim for SENVELGO (active ingredient: velagliflozin), a groundbreaking development… byPallavi MadhirajuNovember 23, 2023